Omega Therapeutics Inc [OMGA] stock is trading at $0.19, up 78.98%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The OMGA shares have gain 28.87% over the last week, with a monthly amount drifted -72.62%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Omega Therapeutics Inc [NASDAQ: OMGA] stock has seen the most recent analyst activity on November 15, 2024, when Raymond James downgraded its rating to a Mkt Perform. Previously, Raymond James started tracking the stock with Outperform rating on June 18, 2024, and set its price target to $12. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $11 on December 08, 2022. Chardan Capital Markets initiated its recommendation with a Buy and recommended $12 as its price target on September 23, 2022.
Omega Therapeutics Inc [OMGA] stock has fluctuated between $0.10 and $4.46 over the past year. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Omega Therapeutics Inc [NASDAQ: OMGA] shares were valued at $0.19 at the most recent close of the market. An investor can expect a potential return of 4636.84% based on the average OMGA price forecast.
Analyzing the OMGA fundamentals
Omega Therapeutics Inc [NASDAQ:OMGA] reported sales of 8.10M for the trailing twelve months, which represents a growth of 214.32%. Gross Profit Margin for this corporation currently stands at -0.6% with Operating Profit Margin at -9.16%, Pretax Profit Margin comes in at -9.03%, and Net Profit Margin reading is -9.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -2.13 and Total Capital is -0.58. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 11.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1123 points at the first support level, and at 0.0314 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2671, and for the 2nd resistance point, it is at 0.3410.
Ratios To Look Out For
For context, Omega Therapeutics Inc’s Current Ratio is 1.61. In addition, the Quick Ratio stands at 1.61 and the Cash Ratio stands at 1.26. Considering the valuation of this stock, the price to sales ratio is 1.32, the price to book ratio is 0.92.
Transactions by insiders
Recent insider trading involved Richard Young, Former board member within 90, that happened on Feb 05 ’25 when 0.55 million shares were purchased.
